VENOMAB IVS: Financial statements 2014
CVR: 35632271
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
VENOMAB IVS (CVR 35632271) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2014 report amounted to DKK 13,885. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 13,885
- Total Assets
- DKK 13,885
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of January 1, 2014, Andreas Hougaard Laustsen-Kiel is registered as director of VENOMAB IVS.
VENOMAB IVS was founded on January 1, 2014.
About VENOMAB IVS
VENOMAB IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2014. The company has been dissolved on 18 January 2018. The company was registered under the industry Uoplyst. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -6,817 the year before. Equity in the 2016 report amounted to DKK 14,518.